HLBBF
Price
$6.00
Change
+$0.65 (+12.15%)
Updated
Jul 2 closing price
Capitalization
4.85B
HLN
Price
$10.26
Change
-$0.00 (-0.00%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
38.4B
28 days until earnings call
Interact to see
Advertisement

HLBBF vs HLN

Header iconHLBBF vs HLN Comparison
Open Charts HLBBF vs HLNBanner chart's image
H. Lundbeck A/S
Price$6.00
Change+$0.65 (+12.15%)
Volume$333
Capitalization4.85B
Haleon
Price$10.26
Change-$0.00 (-0.00%)
VolumeN/A
Capitalization38.4B
HLBBF vs HLN Comparison Chart in %
Loading...
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLBBF vs. HLN commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLBBF is a StrongBuy and HLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (HLBBF: $6.00 vs. HLN: $10.25)
Brand notoriety: HLBBF and HLN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLBBF: 178% vs. HLN: 53%
Market capitalization -- HLBBF: $4.85B vs. HLN: $38.4B
HLBBF [@Pharmaceuticals: Other] is valued at $4.85B. HLN’s [@Pharmaceuticals: Other] market capitalization is $38.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLBBF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 0 green FA rating(s).

  • HLBBF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 0 green, 5 red.
According to our system of comparison, HLN is a better buy in the long-term than HLBBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLBBF’s TA Score shows that 3 TA indicator(s) are bullish while HLN’s TA Score has 4 bullish TA indicator(s).

  • HLBBF’s TA Score: 3 bullish, 3 bearish.
  • HLN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HLN is a better buy in the short-term than HLBBF.

Price Growth

HLBBF (@Pharmaceuticals: Other) experienced а +12.15% price change this week, while HLN (@Pharmaceuticals: Other) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than HLBBF($4.85B). HLN has higher P/E ratio than HLBBF: HLN (29.23) vs HLBBF (13.25). HLN YTD gains are higher at: 8.671 vs. HLBBF (-2.439). HLBBF has higher annual earnings (EBITDA): 2.94B vs. HLN (2.35B). HLBBF has more cash in the bank: 2.88B vs. HLN (994M). HLBBF has less debt than HLN: HLBBF (5.22B) vs HLN (9.46B). HLBBF has higher revenues than HLN: HLBBF (18.9B) vs HLN (11.3B).
HLBBFHLNHLBBF / HLN
Capitalization4.85B38.4B13%
EBITDA2.94B2.35B125%
Gain YTD-2.4398.671-28%
P/E Ratio13.2529.2345%
Revenue18.9B11.3B167%
Total Cash2.88B994M290%
Total Debt5.22B9.46B55%
TECHNICAL ANALYSIS
Technical Analysis
HLBBFHLN
RSI
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
26%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
33%
MACD
ODDS (%)
Bearish Trend 2 days ago
36%
Bearish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
36%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
59%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
48%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFNFX88.160.80
+0.92%
American Funds Fundamental Invs 529F1
ABCIX22.850.15
+0.66%
American Beacon The London Co Inc Eq R5
CIPMX23.55N/A
N/A
Champlain Mid Cap Adv
BOGIX31.48N/A
N/A
SGI Small Cap Core Fund I Shares
INDIX18.44N/A
N/A
ALPS/Kotak India ESG I

HLBBF and

Correlation & Price change

A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
HYEX - HLBBF
21%
Poorly correlated
N/A
HLUBF - HLBBF
18%
Poorly correlated
N/A
HLN - HLBBF
10%
Poorly correlated
-0.10%
HLNCF - HLBBF
8%
Poorly correlated
-5.74%
STEK - HLBBF
2%
Poorly correlated
+12.17%
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.10%
HLNCF - HLN
49%
Loosely correlated
-5.74%
TAK - HLN
37%
Loosely correlated
-0.52%
ZTS - HLN
28%
Poorly correlated
+0.06%
BHC - HLN
25%
Poorly correlated
-0.84%
HCM - HLN
25%
Poorly correlated
+0.76%
More